A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.
A research team at the Medical University of Vienna led by Maria Sibilia has investigated a new combination therapy against cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback